Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Muir, 1987, Cancer Incidence in Five Continents, Vol V. World Health Organization, IARC Scientific Publications n. 88
Grünwald, 1982, Acute myeloid leukemia following treatment of Hodgkin’s disease, A review. Cancer, 50, 676
Pedersen-Bjergaard, 1982, Incidence of acute non-lymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin’s disease, N Engl J Med, 307, 965, 10.1056/NEJM198210143071601
Coltman, 1982, Second malignancies complicating Hodgkin’s disease: A Southwest Oncology Group 10-year follow-up, Cancer Treat Rep, 66, 1023
Valagussa, 1986, Second acute leukemia and other malignancies following treatment for Hodgkin’s disease, J Clin Oncol, 4, 830, 10.1200/JCO.1986.4.6.830
Pedersen-Bjergaard, 1987, Risk of therapy-related leukaemia and preleukaemia after Hodgkin’s disease, Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet, 2, 83
Van Leeuwen, 1989, Increased risk of lung cancer, non-Hodgkin’s lymphoma, and leukemia following Hodgkin’s disease, J Clin Oncol, 7, 1046, 10.1200/JCO.1989.7.8.1046
Coleman, 1977, Hematologic neoplasia in patients treated for Hodgkin’s disease, N Engl J Med, 297, 1249, 10.1056/NEJM197712082972303
Valagussa, 1980, Second malignancies in Hodgkin’s disease: A complication of certain forms of treatment, Br Med J, 1, 216, 10.1136/bmj.280.6209.216
Coleman, 1982, Leukaemias, non-Hodgkin’s lymphomas and solid tumors in patients treated for Hodgkin’s disease, Cancer Surv, 1, 733
Aisenberg, 1983, Acute nonlymphocytic leukemia after treatment for Hodgkin’s disease, Am J Med, 75, 449, 10.1016/0002-9343(83)90348-0
Papa, 1984, Acute leukaemia in patients treated for Hodgkin’s disease, Brit J Haematol, 58, 43, 10.1111/j.1365-2141.1984.tb06057.x
Boivin, 1984, Second cancers after treatment for Hodgkin’s disease: A review, 181
Tester, 1984, Second malignant neoplasms complicating Hodgkin’s disease: The National Cancer Institute Experience, J Clin Oncol, 2, 762, 10.1200/JCO.1984.2.7.762
Andneu, 1990, Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin’s disease, J Clin Oncol, 8, 1148, 10.1200/JCO.1990.8.7.1148
Henry-Amar, 1983, Second cancer after radiotherapy and chemotherapy for early stages of Hodgkin’s disease, J Natl Cancer Inst, 71, 911
Devereux, 1990, Leukaemia complicating treatment for Hodgkin’s disease: The experience of the British National Lymphoma Investigation, Br Med J, 301, 1077, 10.1136/bmj.301.6760.1077
Van Leeuwen, 1987, Splenectomy in Hodgkin’s disease and second leukaemias, Lancet, 2, 210, 10.1016/S0140-6736(87)90782-3
Van der Velden, 1988, Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin’s disease, Int J Cancer, 42, 252, 10.1002/ijc.2910420218
Kaldor, 1990, Leukemia following Hodgkin’s disease, N Engl J Med, 322, 7, 10.1056/NEJM199001043220102
Krikorian, 1979, Occurrence of non-Hodgkin’s lymphoma after therapy for Hodgkin’s disease, N Engl J Med, 300, 452, 10.1056/NEJM197903013000902
Zarrabi, 1989, Second neoplasms in Hodgkin’s disease: Current controversies, Hematol Oncol Clin North Am, 3, 303, 10.1016/S0889-8588(18)30558-6
Bennett, 1991, Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: A 20-year experience, Ann Oncol, 2, 83
Tucker, 1988, Risk of second cancers after treatment for Hodgkin’s disease, N Engl J Med, 318, 76, 10.1056/NEJM198801143180203
Curtis, 1985, Summary: Multiple primary cancers in Connecticut, 1935-82, Natl Cancer Inst Monogr, 68, 219
Storm, 1985, Summary: Multiple primary cancers in Denmark, 1943-80, Natl Cancer Inst Monogr, 68, 411
Coleman, 1987, Second primary malignancy after Hodgkin’s disease, ovarian cancer and cancer of the testis: A population-based cohort study, Br J Cancer, 56, 349, 10.1038/bjc.1987.201
Kaldor, 1987, Second malignancies following testicular cancer, ovarian cancer and Hodgkin’s disease: An international collaborative study among cancer registries, Int J Cancer, 39, 571, 10.1002/ijc.2910390506
Boivin, 1988, Second cancer risk after treatment of Hodgkin’s disease, Cancer, 61, 2541, 10.1002/1097-0142(19880615)61:12<2541::AID-CNCR2820611225>3.0.CO;2-G
Crosby, 1969, Acute granulocytic leukemia, a complication of therapeutic in Hodgkin’s disease?, Clin Res, 17, 463
Somers, 1990, Treatment Strategy in Hodgkin’s Disease, 428
1976
Hellman, 1989, Hodgkin’s disease, 1696
Kaplan, 1958, Nonparametric estimation from incomplete observation, J Am Stat Assoc, 53, 437, 10.1080/01621459.1958.10501452
Cox, 1972, Regression models and life tables (with discussion), J R Statist Soc B, 34, 187, 10.1111/j.2517-6161.1972.tb00899.x
Wartelle, 1983, ‘PIGAS’: An interactive statistical database management system, 124
Dixon, 1985
Boivin, 1984, Second primary cancers following treatment of Hodgkin’s disease, J Natl Cancer Inst, 72, 233
Henry-Amar, 1989, Risk of secondary acute leukemia and pre-leukemia after Hodgkin’s disease: The Institut Gustave-Roussy experience, In Diehl V, Pfreundschuh, M Loeffler M (eds): New aspects in the diagnosis and treatment of Hodgkin’s disease. Recent Results in Cancer Res, 117, 270
Henry-Amar M. Risk of second cancer after therapy for early stage Hodgkin disease: The EORTC experience [abstract 1878]. In Programs and Abstracts of the 17th International Congress of Radiology (Radiation Oncology Section), Paris, 1989, p 272.
Tucker, 1987, Leukemia after therapy with alkylating agents for childhood cancer, J Natl Cancer Inst, 78, 459, 10.1093/jnci/78.3.459
Glicksman, 1982, Second malignant neoplasms in patients successfully treated for Hodgkin’s disease: A Cancer and Leukemia Group B study, Cancer Treat Rep, 66, 1035
Blayney, 1987, Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease, N Engl J Med, 316, 710, 10.1056/NEJM198703193161203
Henry-Amar, 1983, Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin’s disease, J Natl Cancer Inst, 71, 911
Waxman, 1985, Late complications of cytotoxic chemotherapy given for advanced Hodgkin’s disease, 429
Santoro, 1979, Prolonged disease-free survival in MOPP-resistant Hodgkin’s disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD), Cancer Chemother Pharmacol, 2, 101, 10.1007/BF00254081
Rosenberg, 1985, The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin’s disease: 1962-1984, Int J Radiat Oncol Biol Phys, 11, 5, 10.1016/0360-3016(85)90357-8
Meadows, 1989, Second malignant neoplasms following childhood Hodgkin’s disease: Treatment and splenectomy as risk factors, Med Ped Oncol, 17, 477, 10.1002/mpo.2950170525
Gomez, 1983, Occurrence of nonlymphocytic leukemia in a prospective randomized study of treatment for Hodgkin’s disease, Am J Clin Oncol, 6, 319, 10.1097/00000421-198306000-00011
Mauch, 1985, Reduction of fatal complications from combined modality therapy in Hodgkin’s disease, J Clin Oncol, 3, 501, 10.1200/JCO.1985.3.4.501
Coleman, 1982, Functional hyposplenia after splenic irradiation for Hodgkin’s disease, Ann Intern Med, 96, 44, 10.7326/0003-4819-96-1-44
Dailey, 1980, Radiation-induced splenic atrophy in patients with Hodgkin’s disease and non-Hodgkin’s lymphomas, N Eng J Med, 302, 215, 10.1056/NEJM198001243020406
Dailey, 1980, Splenic injury caused by therapeutic irradiation, Am J Surg Path, 5, 325, 10.1097/00000478-198106000-00002
Austyn, 1988, Migration pattern of dendritic cells in the mouse: Homing to T cell-dependent areas of spleens, and binding with marginal zone, J Exp Med, 167, 646, 10.1084/jem.167.2.646
Austyn, 1990, Migration patterns of dendritic leukocytes: Implications for transplantation, Transplantation, 49, 1, 10.1097/00007890-199001000-00001
Kupiec-Weglinski, 1988, Migration patterns of dendritic cells in the mouse: Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissue, J Exp Med, 167, 632, 10.1084/jem.167.2.632
Larsen, 1990, Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection, J Exp Med, 171, 307, 10.1084/jem.171.1.307
Larsen, 1990, Migration and maturation of Langerhans cells in skin transplants and ex-plants, J Exp Med, 172, 1483, 10.1084/jem.172.5.1483
Li, 1987, Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease, N Engl J Med, 317, 707, 10.1056/NEJM198709103171112
Henry-Amar, 1987, Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease, N Engl J Med, 317, 707, 10.1056/NEJM198709103171112
Kaldor, 1987, Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease, N Engl J Med, 317, 708
Kim, 1982, Pathology panel for lymphoma clinical studies: A comprehensive analysis of cases accumulated since its inception, J Natl Cancer Inst, 68, 43
Zarrabi, 1989, Second neoplasms in Hodgkin’s disease: Current controversies, Proc of ASCO. J Clin Oncol, 8, 292
Bookman, 1986, Concomitant illness in patients treated for Hodgkin’s disease, Cancer Treat Rev, 13, 77, 10.1016/0305-7372(86)90015-0
Baccarani, 1980, Second malignancy in patients treated from Hodgkin’s disease, Cancer, 46, 1735, 10.1002/1097-0142(19801015)46:8<1735::AID-CNCR2820460806>3.0.CO;2-3
Nelson, 1981, Second malignant neoplasms in patients treated for Hodgkin’s disease with radiotherapy or radiotherapy and chemotherapy, Cancer, 48, 2386, 10.1002/1097-0142(19811201)48:11<2386::AID-CNCR2820481109>3.0.CO;2-B